DK300487A - Lactamer med antihypertensiv virkning samt fremgangsmaader til deres fremstilling - Google Patents

Lactamer med antihypertensiv virkning samt fremgangsmaader til deres fremstilling

Info

Publication number
DK300487A
DK300487A DK300487A DK300487A DK300487A DK 300487 A DK300487 A DK 300487A DK 300487 A DK300487 A DK 300487A DK 300487 A DK300487 A DK 300487A DK 300487 A DK300487 A DK 300487A
Authority
DK
Denmark
Prior art keywords
lactames
procedures
preparation
hypertensive effect
hypertensive
Prior art date
Application number
DK300487A
Other languages
English (en)
Other versions
DK300487D0 (da
DK170840B1 (da
Inventor
Gary A Flynn
Douglas W Beight
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK300487D0 publication Critical patent/DK300487D0/da
Publication of DK300487A publication Critical patent/DK300487A/da
Application granted granted Critical
Publication of DK170840B1 publication Critical patent/DK170840B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
DK300487A 1986-06-13 1987-06-12 Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension DK170840B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87375486A 1986-06-13 1986-06-13
US87375486 1986-06-13
AT269187 1987-10-12
AT0269187A AT398425B (de) 1986-06-13 1987-10-12 Neue tricyclische lactame

Publications (3)

Publication Number Publication Date
DK300487D0 DK300487D0 (da) 1987-06-12
DK300487A true DK300487A (da) 1987-12-14
DK170840B1 DK170840B1 (da) 1996-02-05

Family

ID=25598925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300487A DK170840B1 (da) 1986-06-13 1987-06-12 Tricycliske lactamer indeholdende en benzazepingruppe, lægemiddel indeholdende sådanne lactamer samt anvendelse deraf til fremstilling af et lægemiddel til behandling af hypertension

Country Status (12)

Country Link
EP (1) EP0249223B1 (da)
JP (1) JP2542213B2 (da)
KR (1) KR950014572B1 (da)
AR (1) AR247213A1 (da)
AT (1) AT398425B (da)
AU (1) AU601433B2 (da)
CA (1) CA1337654C (da)
DK (1) DK170840B1 (da)
ES (1) ES2044870T3 (da)
GR (1) GR3006802T3 (da)
IE (1) IE61476B1 (da)
ZA (1) ZA874107B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
EP0492369B1 (en) * 1990-12-21 1997-09-17 Merrell Pharmaceuticals Inc. Novel amino and nitro containing tricyclic compounds useful as inhibitors of ace
US5455242A (en) * 1991-09-27 1995-10-03 Merrell Dow Pharmaceuticals Inc. Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
CA2078759C (en) * 1991-09-27 2003-09-16 Alan M. Warshawsky Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
AU657793B2 (en) * 1991-09-27 1995-03-23 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
US5457196A (en) * 1991-09-27 1995-10-10 Merrell Dow Pharmaceuticals Inc. 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
DE69220744T2 (de) * 1991-09-27 1997-11-13 Merrell Pharma Inc 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung
ATE164593T1 (de) * 1992-02-14 1998-04-15 Merrell Pharma Inc Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
AU669364B2 (en) * 1992-05-15 1996-06-06 Merrell Pharmaceuticals Inc. Novel mercaptoacetylamido pyridazo(1,2)pyridazine, pyrazolo(1,2)pyridazine, pyridazo(1,2-a)(1,2)diazepine and pyrazolo(1,2-a)(1,2)diazepine derivatives useful as inhibitors of enkephalinase and ace
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
ES2155852T3 (es) * 1992-10-30 2001-06-01 Merrell Pharma Inc Derivados de lactama biciclica de mercaptoacetilamida utiles como inhibidores de encefalinasa y eca.
US5654294A (en) * 1993-05-13 1997-08-05 Bristol-Myers Squibb Spiro lactam dual action inhibitors
US5362727A (en) * 1993-07-26 1994-11-08 Bristol-Myers Squibb Substituted azepino[2,1-a]isoquinoline compounds
WO1995014663A2 (en) * 1993-11-19 1995-06-01 Merrell Pharmaceuticals Inc. Novel process for preparing (s)-1-[2(s)-(1,3-dihydro-1,3-dioxo-isoindo-2-yl)-1-oxo-3-phenylpropyl]-1,2,3,4-tetrahydro-2-pyridine-carboxylic acid methyl ester and intermediates thereof
CN1142831A (zh) * 1994-02-14 1997-02-12 默里尔药物公司 用作脑啡肽酶和ace抑制剂的新的2-取代的1，2-二氢化茚-2-巯基乙酰胺二硫化物衍生物
JP3596778B2 (ja) * 1994-02-14 2004-12-02 メレル ファーマスーティカルズ インコーポレーテッド エンケファリナーゼ及びａｃｅの阻害剤として有用な、新規なメルカプトアセチルアミドジスルフィド誘導体類
HUT74584A (en) * 1994-02-14 1997-01-28 Merrell Pharma Inc Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
ATE191485T1 (de) * 1994-02-14 2000-04-15 Merrell Pharma Inc Mercaptoacetylamid-1,3,4,5- tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5484783A (en) * 1994-03-24 1996-01-16 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives
NZ282565A (en) * 1994-03-24 1999-11-29 Merrell Pharma Inc Condensed mercaptoacetylamidedisulphidebenzazepines used in treating elevated cholesterol levels, atherosclerosis, and hypotriglyceridemia
DE69514912T2 (de) * 1994-03-24 2000-10-05 Merrell Pharmaceuticals Inc., Cincinnati Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten
JP3658408B2 (ja) * 1994-12-21 2005-06-08 アベンティス・ファーマスーティカルズ・インコーポレイテッド エンケファリナーゼおよびアンギオテンシン変換酵素の阻害剤の中間体を製造する新規な方法およびその中間体
US5641880A (en) * 1994-12-21 1997-06-24 Hoechst Marion Roussel, Inc. Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
GB0119305D0 (en) 2001-04-12 2001-10-03 Aventis Pharma Gmbh Mercaptoacetylamide derivatives,a process for their preparation and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AR247213A1 (es) 1994-11-30
JPS62298591A (ja) 1987-12-25
EP0249223A2 (en) 1987-12-16
AT398425B (de) 1994-12-27
JP2542213B2 (ja) 1996-10-09
DK300487D0 (da) 1987-06-12
GR3006802T3 (da) 1993-06-30
AU601433B2 (en) 1990-09-13
IE61476B1 (en) 1994-11-02
KR950014572B1 (ko) 1995-12-08
AU7402287A (en) 1987-12-17
ATA269187A (de) 1994-04-15
CA1337654C (en) 1995-11-28
EP0249223A3 (en) 1989-01-25
ES2044870T3 (es) 1994-01-16
ZA874107B (da) 1987-12-09
EP0249223B1 (en) 1992-10-14
DK170840B1 (da) 1996-02-05
IE871547L (en) 1987-12-13
KR880000399A (ko) 1988-03-25

Similar Documents

Publication Publication Date Title
DK300487A (da) Lactamer med antihypertensiv virkning samt fremgangsmaader til deres fremstilling
DK120188D0 (da) Aminomethylheterocycler, fremgangsmaader til deres fremstilling samt deres anvendelse
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK454188D0 (da) 2-oxo-1-sulfonylaminocarbonyl-azetidiner samt fremgangsmaade til deres fremstilling
DK52388A (da) Polyaminderivater samt fremgangsmaader til deres fremstilling
DK403287D0 (da) 1,4-dihydropyridinderivater med calciumagonist- og alfa1-antagonist-virkning samt fremgangsmaader til deres fremstilling
DK6285D0 (da) Kautsjuk med decarboxylerede kolofoniumsyrer samt fremstilling deraf
DK325487A (da) Farmaceutiske sammensaetninger til parenteral applikation samt deres fremstilling
DK74086A (da) Forbindelser med pesticid virkning samt fremgangsmaade til deres fremstilling
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK178589D0 (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK540887D0 (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK548086A (da) Nitroanthracycliner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK201884A (da) Farmaceutisk praeparat med anti-hypertensiv virkning
DK488487D0 (da) Indolderivater og fremgangsmaade til deres fremstilling samt parasitbekaempelsesmidler med indhold deraf
DK440688A (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK380787A (da) Decahydro-2-naphthylalkylaminer, fremgangsmaade til deres fremstilling samt deres anvendelse
DK630788D0 (da) N-substituerede dichlormaleinimider, fremgangsmaade til deres fremstiling samt deres anvendelse
DK402585D0 (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
DK404587A (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK259089D0 (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK139487A (da) Gametocide pyrazoler samt fremgangsmaader til deres fremstilling
DK264788A (da) Azolyl-tetrahydrofuran-2-yliden-methaner, fremgangsmaader til deres fremstilling samt deres anvendelse
DK574087D0 (da) Anti-hypertensivt praeparat
DK436588A (da) Substituerede pyridiner, fremgangsmaader til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired